![Phillip Febbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Febbo
Technik-/Wissenschafts-/F&E-Leiter bei
VERACYTE, INC.
Vermögen: 7 Mio $ am 31.05.2026
Profil
Phillip G. Febbo ist Chief Medical Officer von Illumina, Inc. Er ist außerdem Mitglied des Vorstands von Varian Medical Systems, Inc. sowie des American College of Medical Genetics & Genomics und der Acmg Foundation For Genetic & Genomic Medicine und Mitglied der American Society for Clinical Investigation. In seiner bisherigen Laufbahn war Dr. Febbo Chief Medical Officer bei Genomic Health, Inc. sowie außerordentlicher Professor an der Duke University und Professor an der University of California, San Francisco. Phillip G. Febbo erwarb einen Bachelor-Abschluss am Dartmouth College und einen Doktortitel an der University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERACYTE, INC. 0,19 % | 02.06.2026 | 149.797 ( 0,19 % ) | 7 Mio $ | 31.05.2026 |
Aktive Positionen von Phillip Febbo
| Unternehmen | Position | Beginn |
|---|---|---|
| VERACYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2023 |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | 01.01.2009 |
Acmg Foundation For Genetic & Genomic Medicine
 Acmg Foundation For Genetic & Genomic Medicine Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
Reagan-udall Foundation
 Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | 01.06.2021 |
Ehemalige bekannte Positionen von Phillip Febbo
| Unternehmen | Position | Ende |
|---|---|---|
| ILLUMINA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.08.2023 |
American College of Medical Genetics & Genomics
 American College of Medical Genetics & Genomics Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.03.2023 |
Varian, Inc.
 Varian, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells scientific instruments & vacuum technology equipment | Direktor/Vorstandsmitglied | 01.08.2021 |
| VARIAN MEDICAL SYSTEMS, INC. | Direktor/Vorstandsmitglied | 15.04.2021 |
| GENOMIC HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2018 |
Ausbildung von Phillip Febbo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Varian, Inc.
Varian, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells scientific instruments & vacuum technology equipment | Health Technology |
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
American College of Medical Genetics & Genomics
American College of Medical Genetics & Genomics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reagan-udall Foundation
Reagan-udall Foundation The Reagan-Udall Foundation is a non-profit company dedicated to advancing regulatory science and innovation. The company is based in Washington, DC. The foundation collaborates with various stakeholders to enhance public health and safety through research and development initiatives. Susan C. Winckler has been the CEO of the company since 2020. | |
Acmg Foundation For Genetic & Genomic Medicine
Acmg Foundation For Genetic & Genomic Medicine Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
